Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
Patent 8030296 Issued on October 4, 2011. Estimated Expiration Date: March 3, 2026. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
There is provided a compound of Formula I wherein X is a ring system; R1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; R2 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein when X is a steroidal structure and both of R1 and R2 are sulphamate groups, the steroidal ring system (X) represents an oestrogen; and wherein said compound is capable of inhibiting steroid sulphatase (STS) activity and/or is capable of acting as a modulator of cell cycling and/or as a modulator of apoptosis and/or as a modulator of cell growth. There is also provided a compound of Formula VIII wherein R2 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; and wherein said compound is capable of inhibiting steroid sulphatase (STS) activity and/or is capable of acting as a modulator of cell cycling and/or as a modulator of apoptosis and/or as a modulator of cell growth.
Other References
Romer et al., Institute of Bioinorganic and Radiopharmaceutical Chemistry Annual Report, Sulfamates of 3-Hydroxy-estra-1-3-5(10)-triene Derivatives, pp. 182-187 (1996).
Romer et al., Institute of Bioinorganic and Radiopharmaceutical Chemistry Annual Report,C NMR Spectroscopic Characterization of some Sulfamates of 3-Hydroxy-estra-1,3,5(10)-triene Derivatives, pp. 188-191 (1996).
Zhang, H., et al., “Discovery and Structure-Activity Relationship of N-Phenyl-1H-Pyrazolo [3,4-b] Quinolin-4-Amines as a new Series of Potent Apoptosis Inducers”, Bioorganic & Medicinal Chemistry 16, pp. 222-231, (2008 ).
Huang, Y., et al., “CIL-102 Interacts with Microtubule Polymerization and Causes Mitotic Arrest following Apoptosis in the Human Prostate Cancer PC-3 Cell Line”, The Journal of Biological Chemistry, vol. 280, No. 4, pp. 2771-2779, issue dated Jan. 28, 2005.
Jung, H., et al., “Embellistatin, a Microtubule Polymerization Inhibitor, Inhibits Angiogenesis Both in Vitro and Vivo”, Biochemical and Biophysical Research Communications 353 (2007) 376-380, Received Dec. 2, 2006.
Sigfrid Schwarz et: Synthesis of estrogen sulfamates: Compounds with a novel endocrinological profile, Steroids, 1996, vol. 61, December, p. 711.
J. Romer et al: 13C NMR Spectroscopic Characterization of Some Sulfamates of 3-Hydroxy-estra-1,3,5(10)-triene Derivatives, 188-191.
J. Romer et al: Sulfamates of 3-Hydroxy-estra-1-3-5(10)-triene Derivatives, 182-187.
M J Reed et al: The development of steroid sulphatase inhibitors Endocrine-Related Cancer (1996)3, 9-23.
Peter Nussbaumer et al: “4,4′-Benzophenone-O, O′-disulfamate: A Potent Inhibitor of Steroid Sulfatase”, Bioorganic & Medicinal Chemistry Letters 12 (2002) 2093-2095.
MacCarthy-Morrogh, L et al: Differential effects of estrone and estrone-3-o-sulfamate derivates on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells, Cancer Res 2000, Oct 1; 60(19),:5441-50.
Lokind et al: “Oral bioavailability of 17.beta-estradiol and prodrugs tested in rats, pigs and dogs” Int J Pharm (1996), 127(2), 155-64.
Brunner H et al: “Synthese and Antitumoraktivitat von cis-Dichloroplatin (II)-Komplexen mit Ostradiolderivaten” Monatshefte Fur Chemie, Springer Verlag. Wien, AT, vol. 124, No. I, (1993), pp. 83-102.
Woo L W L et al: 'Oestrone 3-0-(N-acetyl) stilphamate, a potential molecular proble of the active site of oestrone sulphatase Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 24, (1997), pp. 3075-3080.
Kasch, H. et al: “in vitro selection of sulfatasc inhibitors for tumor diagnosis with PET and for tumor therapy” XP002182697 Forschungszent. Rossendorf (1999), FZR-286, 54-57.
Nedvidkova, J et al: “Estrogenic effect of estradiol-sulfamate on the male rat anterior pituitary” XP002182696 J. Steroid Biochem. Mol Biol. (1998), 67(4), pp. 359-362.
Romer, Johannes et al: “Preparation and characterization of the sulfamates of estra-3, 17.xi,-diols. Rapis conversion of 16α-fluoroestradiol into 16.alpha-fluorestradiol-3, 17β-disul famate”. J. Prakt. Chem. (1999), 341, vol. (6).
Theodora VoskogLou-Nomokos et al. (Clinical Research, vol. 9, pp. 4227-4239, Sep. 15, 2003.
Draetta et al “Section V. Topics in Biology”, Annual Reports in Medicinal Chemistry, 31, 1996, Academic Press, San Diego, pp. 241-248.
March 3, 2026. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
